Collagen Solutions PLC Director/PDMR Shareholding (0283M)

TIDMCOS

RNS Number : 0283M

Collagen Solutions PLC

25 July 2017

This announcement contains inside information

Collagen Solutions Plc

(the "Company")

Director/PDMR Dealing

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that it was notified today that David Evans, Chairman of the Company, has purchased 900,000 ordinary shares in the Company ("Ordinary Shares") at 5.1 pence per Ordinary Share.

Following the transaction, David Evans' total beneficial holding in the Company has increased to 39,394,554 Ordinary Shares representing 12.15 per cent. of the issued ordinary share capital of the Company.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ---------------------------------------------------------- 
 a)   Name                       David Evans 
---  -------------------------  ------------------------------- 
 2    Reason for the notification 
---  ---------------------------------------------------------- 
 a)   Position/status                       Chairman 
---  -------------------------  ------------------------------- 
 b)   Initial notification       Initial 
       /Amendment 
---  -------------------------  ------------------------------- 
 3    Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ---------------------------------------------------------- 
 a)   Name                       Collagen Solutions plc 
---  -------------------------  ------------------------------- 
 b)   LEI                        N/A 
---  -------------------------  ------------------------------- 
 4    Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ---------------------------------------------------------- 
 a)   Description of             Ordinary shares of 1p each 
       the financial 
       instrument, type 
       of instrument              ISIN: GB00B94T6Y14 
 
       Identification 
       code 
---  -------------------------  ------------------------------- 
 b)   Nature of the              Purchase of shares 
       transaction 
---  -------------------------  ------------------------------- 
 c)   Price(s) and volume(s)       Price(s)          Volume(s) 
                                   ----------------  ---------- 
                                    5.1p per share    900,000 
                                   ----------------  ---------- 
---  -------------------------  ------------------------------- 
 d)   Aggregated information 
 
 
       - Aggregated volume         N/A - single transaction 
 
 
       - Price 
---  -------------------------  ------------------------------- 
 e)   Date of the transaction    25 July 2017 
---  -------------------------  ------------------------------- 
 f)   Place of the transaction   London Stock Exchange 
---  -------------------------  ------------------------------- 
 

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic, an osteochondral scaffold for repairing cartilage defects in the knee. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For additional information on Collagen Solutions, please visit: www.collagensolutions.com

Enquiries:

 
  Collagen Solutions Plc                                            Contact via Walbrook 
 Jamal Rushdy, Chief Executive 
  Officer 
 Gill Black, Chief Financial 
  Officer 
 
 Cenkos Securities plc (Nominated                                     Tel: [phone] 
  Adviser and Broker) 
  Stephen Keys 
  Steve Cox 
  Callum Davidson 
 
 Walbrook PR                               Tel: [phone] or [e-mail] 
 Mike Wort                                                            Mob: [phone] 
 Anna Dunphy                                                          Mob: [phone] 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHOKPDNKBKDQOB

(END) Dow Jones Newswires

July 25, 2017 06:36 ET (10:36 GMT)